ArticleJCO precision oncology2019

Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With Glioblastoma.

Brian M Alexander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.